Search results
Added:
11 months ago
ESC-HFA 23 - Dr Jawad Haider Butt (Copenhagen University Hospital, DK) outlines the findings of a patient-level meta-analysis of the DAPA-HF and DELIVER trials, which studied the safety and effectiveness of dapagliflozin on patients with both peripheral arterial disease and heart failure. These trials covered the spectrum of patients with heart failure.
The findings of this meta-analysis suggest…
View more
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years.1 It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Added:
6 years ago
Gemma Figtree discusses the CANVAS trial - canagliflozin and heart failure in type 2 diabetes mellitus.
Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA.
View more
Added:
2 years ago
Added:
3 years ago
Chagas disease was initially described as an endemic health problem in a few countries in South America – mainly Argentina and Brazil – and one of the consequences of the disease, heart damage, made it an interesting issue for healthcare professionals, from epidemiologists to cardiologists.1 Chagas cardiomyopathy (ChCM) is now recognised as a cardiovascular disorder, diagnosed and treated not…
View more
Added:
3 years ago
Aim: Chronic heart failure (CHF) is a common cause of mortality and morbidity. Obesity influences the CHF development and prognosis. This study was conducted to assess effect of heart failure reversal therapy (HFRT), a combination of panchakarma and allied therapies, on anthropometric parameters in CHF patients.
Methods: This retrospective study was conducted on data of patients who visited…
View more
Added:
4 years ago
Dr Florian Krackhardt (Charité – Universitätsmedizin Berlin, Berlin, DE) diskutiert Me & My Heart (eMocial) Studie - Eine randomisierte Auswertung eines neuen Smartphone-basierten Tool zur Verbesserung der Therapie-Einhaltung bei Patienten mit akutem Koronarsyndrom.
Fragen:
1.Was ist die Me & My Heart (eMocial) Studie und wer war die Zielgruppe?
2.Können Sie uns die Anwendung der…
View more
Added:
2 years ago
In this short video interview filmed at EHRA 2022, Dr Dhiraj Gupta (Liverpool Heart and Chest NHS Foundation Trust, UK) discusses research surrounding atrial fibrillation in heart failure, and the considerations that must be taken when approaching AF ablation.
Discussion points:
Research surrounding atrial fibrillation in heart failure
Conflicts in this research
Further research required
…
View more
Added:
3 years ago
Systemic means ‘pertaining to or affecting the whole body’ as opposed to a localised condition. A systemic disease is one that affects a number of organs and tissues, or the body as a whole. Systemic diseases, according to WHO classification,1 and cardiac diseases that developed during their course, are listed in Table 1.
Download original
Thyroid diseases, pheochromocytoma and growth hormone…
View more
Added:
7 months ago
« First